About Bestrophin-4
Bestrophin-4 (BEST4) is a protein
from Homo sapiens identified by UniProt accession
Q8NFU0, 473 residues long.
MolForge cross-references it against 0 known binders and
29 disease associations.
Target properties
| Protein name | Bestrophin-4 |
| UniProt accession | Q8NFU0 |
| Gene | BEST4 |
| Organism | Homo sapiens |
| Length | 473 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (29)
Diseases linked to this target (Open Targets).
- apolipoprotein B measurement · score 0.13
- head and neck squamous cell carcinoma · score 0.12
- low density lipoprotein cholesterol measurement · score 0.07
- colorectal cancer · score 0.05
- platelet component distribution width · score 0.04
- intraocular pressure measurement · score 0.04
- colorectal adenocarcinoma · score 0.04
- Barrett's esophagus · score 0.03
- Red cell distribution width · score 0.03
- ulcerative colitis · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NFU0-F1 | alphafold | PREDICTED | 82.37 | — |
Amino-acid sequence (473 residues)
MTVSYTLKVA EARFGGFSGL LLRWRGSIYK LLYKEFLLFG ALYAVLSITY RLLLTQEQRY VYAQVARYCN RSADLIPLSF VLGFYVTLVV NRWWSQYTSI PLPDQLMCVI SASVHGVDQR GRLLRRTLIR YANLASVLVL RSVSTRVLKR FPTMEHVVDA GFMSQEERKK FESLKSDFNK YWVPCVWFTN LAAQARRDGR IRDDIALCLL LEELNKYRAK CSMLFHYDWI SIPLVYTQVV TIAVYSFFAL SLVGRQFVEP EAGAAKPQKL LKPGQEPAPA LGDPDMYVPL TTLLQFFFYA GWLKVAEQII NPFGEDDDDF ETNQLIDRNL QVSLLSVDEM YQNLPPAEKD QYWDEDQPQP PYTVATAAES LRPSFLGSTF NLRMSDDPEQ SLQVEASPGS GRPAPAAQTP LLGRFLGVGA PSPAISLRNF GRVRGTPRPP HLLRFRAEEG GDPEAAARIE EESAESGDEA LEP
Explore Bestrophin-4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets